相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery
Claudia Moreira de Brito et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2021)
Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery
Daniel Porat et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
The use of nonsteroidal anti-inflammatory drugs after sleeve gastrectomy
Alan Begian et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2021)
Esophageal High-Resolution Manometry Can Unravel the Mechanisms by Which Different Bariatric Techniques Produce Different Reflux Exposures
Salvatore Tolone et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Thyroid Homeostasis After Bariatric Surgery in Obese Cases
Feyzi Gokosmanoglu et al.
OBESITY SURGERY (2020)
DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register
Michela Cini et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2020)
Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?
Marco Castellana et al.
ENDOCRINE (2020)
Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation
Marko Miklic et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Reduced bioavailability of oral amoxicillin tablets compared to suspensions in Roux-en-Y gastric bypass bariatric subjects
Maiara Camotti Montanha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Assessment of Contraceptive Counseling and Contraceptive Use in Women After Bariatric Surgery
Michiel A. Damhof et al.
OBESITY SURGERY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Long-term adverse events after sleeve gastrectomy or gastric bypass: a 7-year nationwide, observational, population-based, cohort study
Jeremie Thereaux et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Effect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?
Ana Belen Rivas et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Impact of Bariatric Surgery on the Pharmacokinetics Parameters of Amoxicillin
Marina Becker Sales Rocha et al.
OBESITY SURGERY (2019)
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature
Arik Dahan et al.
OBESITY SURGERY (2019)
Body mass index and the risk of infection - from underweight to obesity
J. Dobner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Development and applications of a physiologically-based model of paediatric oral drug absorption
T. N. Johnson et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality
Orna Reges et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Self-Reported Weight-Loss Methods and Weight Change: Ten-Year Analysis in the Swedish Obese Subjects Study Control Group
Edit Zentenius et al.
OBESITY (2018)
Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement
Maurizio De Luca et al.
OBESITY SURGERY (2018)
Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy
Andrew T. Strong et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
The effect of bariatric surgery on direct-acting oral anticoagulant drug levels
Amihai Rottenstreich et al.
THROMBOSIS RESEARCH (2018)
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Luigi Angrisani et al.
OBESITY SURGERY (2018)
The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study
Dino Kroell et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
Obesity and Altered Aspirin Pharmacology
Nicholas B. Norgard
CLINICAL PHARMACOKINETICS (2018)
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study
Dagmar Kubitza et al.
THROMBOSIS JOURNAL (2018)
Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management
A. P. van Beek et al.
OBESITY REVIEWS (2017)
TSH Normalization in Bariatric Surgery Patients After the Switch from l-Thyroxine in Tablet to an Oral Liquid Formulation
Poupak Fallahi et al.
OBESITY SURGERY (2017)
Is Daily Low-Dose Aspirin Safe to Take Following Laparoscopic Roux-en-Y Gastric Bypass for Obesity Surgery?
Xian Kang et al.
OBESITY SURGERY (2017)
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Daniel S. Strand et al.
GUT AND LIVER (2017)
Hidradenitis Suppurativa Advances in Diagnosis and Treatment
Ditte Marie Lindhardt Saunte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Psychiatric disorders and obesity: A review of association studies
T. M. Rajan et al.
JOURNAL OF POSTGRADUATE MEDICINE (2017)
The effect of morbid obesity on morphine glucuronidation
Celia Lloret-Linares et al.
PHARMACOLOGICAL RESEARCH (2017)
Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery
Carrie A. Krieger et al.
PHARMACOTHERAPY (2017)
Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects
Lorry Hachon et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2017)
Comparison of oral antibiotic failure rates in post-Roux-en-Y gastric bypass patients versus controls
David J. Roy et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2017)
Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass
Allison R. Schulman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Aspirin responsiveness changes in obese patients following bariatric surgery
Nicholas B. Norgard et al.
CARDIOVASCULAR THERAPEUTICS (2017)
Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery
Dino Kroell et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance
Karlyn A. Martin et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Benefits of Prophylactic Proton Pump Inhibitors after Roux-en-Y Gastric Bypass Surgery: A Retrospective Study
Ph. Plaeke et al.
ACTA CHIRURGICA BELGICA (2016)
Obesity: impact of infections and response to vaccines
C. Tagliabue et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Influence of bariatric surgery on the use of medication
Jan Peter Yska et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Drug disposition before and after gastric bypass: fenofibrate and posaconazole
Ina Gesquiere et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays
R. Gosselin et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations
Carmil Azran et al.
OBESITY REVIEWS (2016)
The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study
Lieke Mitrov-Winkelmolen et al.
OBESITY SURGERY (2016)
NSAID Use after Bariatric Surgery: a Randomized Controlled Intervention Study
Jan Peter Yska et al.
OBESITY SURGERY (2016)
The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study
Usha K. Coblijn et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass
Xian Kang et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2016)
Complications of bariatric surgery: Presentation and emergency management
Radwan Kassir et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations
Ina Gesquiere et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Christian T. Ruff et al.
LANCET (2015)
Absorption-Enhancing Effects of Bile Salts
Eskandar Moghimipour et al.
MOLECULES (2015)
The impact of bariatric surgery on quality of life: a systematic review and meta-analysis
N. Lindekilde et al.
OBESITY REVIEWS (2015)
The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
Margreke J. Brill et al.
PHARMACEUTICAL RESEARCH (2015)
Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery
Kristine J. Steffen et al.
PHARMACOTHERAPY (2015)
Decreased Escitalopram Concentrations Post-Roux-en-Y Gastric Bypass Surgery
Mark A. Marzinke et al.
THERAPEUTIC DRUG MONITORING (2015)
Nonsteroidal Anti-inflammatory Drugs and the Risk for Anastomotic Failure A Report From Washington State's Surgical Care and Outcomes Assessment Program (SCOAP)
Timo W. Hakkarainen et al.
JAMA SURGERY (2015)
Effects of Posture and Meal Volume on Gastric Emptying, Intestinal Transit, Oral Glucose Tolerance, Blood Pressure and Gastrointestinal Symptoms After Roux-en-Y Gastric Bypass
Nam Q. Nguyen et al.
OBESITY SURGERY (2015)
Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies
Valerie Wu Chao Ying et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2015)
Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care
N. G. L. Jager et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
PBPK models for the prediction of in vivo performance of oral dosage forms
Edmund S. Kostewicz et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis
Margreke J. E. Brill et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)
Paul A. Reilly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
The pharmacology of novel oral anticoagulants
Tracy A. DeWald et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2014)
Management of Anastomotic Ulcers After Roux-en-Y Gastric Bypass: Results of an International Survey
Daniel C. Steinemann et al.
OBESITY SURGERY (2014)
The Effect of Bariatric Surgery on Intestinal Absorption and Transit Time
Kirstin A. Carswell et al.
OBESITY SURGERY (2014)
An Evidence-Based Algorithm for the Management of Marginal Ulcers following Roux-en-Y Gastric Bypass
William R. J. Carr et al.
OBESITY SURGERY (2014)
Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease
Andrew Darlington et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Warfarin dosing after bariatric surgery: a retrospective study of 10 patients previously stable on chronic warfarin therapy
A. M. Schullo-Feulner et al.
CLINICAL OBESITY (2014)
Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
Sweta Tandra et al.
ANNALS OF SURGERY (2013)
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
Nynke G. L. Jager et al.
BMC CANCER (2013)
Obesity and the risk and outcome of infection
R. Huttunen et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Bile salts and their importance for drug absorption
Rene Holm et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
A Comparison of Duloxetine Plasma Levels in Postbariatric Surgery Patients Versus Matched Nonsurgical Control Subjects
James L. Roerig et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery
L. Sjostrom
JOURNAL OF INTERNAL MEDICINE (2013)
Comparison of initial warfarin response in obese patients versus non-obese patients
Jessica L. Wallace et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass
C. Dirksen et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient-2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery
Jeffrey I. Mechanick et al.
OBESITY (2013)
Oral Liquid L-Thyroxine (L-T4) May Be Better Absorbed Compared to L-T4 Tablets Following Bariatric Surgery
Ilenia Pirola et al.
OBESITY SURGERY (2013)
Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy
Adriane N. Irwin et al.
PHARMACOTHERAPY (2013)
Omental patch repair effectively treats perforated marginal ulcer following Roux-en-Y gastric bypass
Mark R. Wendling et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2013)
Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation
Thomas Gremmel et al.
TRANSLATIONAL RESEARCH (2013)
Pros and cons of new oral anticoagulants
Kenneth A. Bauer
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)
The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
Giselle G. Hamad et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes
Adam S. Darwich et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Individualization of Tamoxifen Treatment for Breast Carcinoma
L. Binkhorst et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery
Julie De Smet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Effect of gastric bypass surgery on azithromycin oral bioavailability
Raj S. Padwal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Accelerated Gastric Emptying but No Carbohydrate Malabsorption 1 Year After Gastric Bypass Surgery (GBP)
Gary Wang et al.
OBESITY SURGERY (2012)
Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort
James L. Roerig et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2012)
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole Monitoring of Intraluminal and Plasma Drug Concentrations
Jeroen Walravens et al.
CLINICAL PHARMACOKINETICS (2011)
Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
L. Madlensky et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports
Cecile Ciangura et al.
CONTRACEPTION (2011)
Can a Short Course of Prophylactic Low-dose Proton Pump Inhibitor Therapy Prevent Stomal Ulceration After Laparoscopic Roux-en-Y Gastric Bypass?
Mathieu Andre D'Hondt et al.
OBESITY SURGERY (2010)
Tamoxifen Malabsorption After Roux-en-Y Gastric Bypass Surgery: Case Series and Review of the Literature
Shannon M. Wills et al.
PHARMACOTHERAPY (2010)
Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention
Nathalie Bonello-Palot et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Impact of bariatric surgery on female reproduction
Zaher O. Merhi
FERTILITY AND STERILITY (2009)
Seven cases of gastric perforation in Roux-en-Y gastric bypass patients: What lessons can we learn?
Kent C. Sasse et al.
OBESITY SURGERY (2008)
Pregnancy outcomes after laparoscopic Roux-en-Y gastric bypass
Jitesh A. Patel et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2008)
Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels - A meta-analysis of 21 cohort studies including more than 300,000 persons
Rik P. Bogers et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of Clopidogrel before percutaneous coronary intervention
Dirk Sibbing et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Risk of massive upper gastrointestinal bleeding in gastric bypass patients taking clopidogrel
Joseph A. Caruana et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2007)
Pregnancy outcomes after gastric-bypass surgery
Tuoc Dao et al.
AMERICAN JOURNAL OF SURGERY (2006)
Predictors of endoscopic findings after Roux-en-Y gastric bypass
Jason A. Wilson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old
Kenneth F. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Obesity and infection
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2006)
Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (Rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects
D Kubitza et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model
JS Seaman et al.
PSYCHOSOMATICS (2005)
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement
J Stangier et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects
M Tamminen et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Contraceptive treatment after biliopancreatic diversion needs consensus
EG Gerrits et al.
OBESITY SURGERY (2003)
Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing
UM Hollenstein et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
分享论文
